For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Amiodarone hydrochloride - Arrhythmias
PAD Profile : Amiodarone hydrochloride - Arrhythmias
Traffic Light Status
Status 1 of 2.
- Tablets
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Flecainide acetate
- Propafenone hydrochloride
- Digoxin
- Sotalol hydrochloride
- Atenolol
- Mexiletine hydrochloride
- Bisoprolol fumarate
- Disopyramide
- Lidocaine
- Metoprolol tartrate
- Procainamide hydrochloride
- Propranolol hydrochloride
- Verapamil hydrochloride
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for Amiodarone (with some local adaption) for patients within adult services.
Tthe NHS England guidance ‘Items which should not routinely be prescribed in primary care: Guidance for CCGs’ Version 2, June 2019 states that amiodarone is only to be initiated by specialists in exceptional circumstances where other treatments cannot be used or have failed:
1) in line with NICE Guidance CG180 https://www.nice.org.uk/guidance/CG180 in patients:
- prior and post electrocardioversion / ablation; OR
- who have heart failure or left ventricular impairment; OR
- requiring pharmacological cardioversion; OR
- undergoing cardiothoracic surgery
2) in patients with ventricular tachycardia / ventricular fibrillation and tachyarrhythmias associated with Wolff-Parkinson-White syndrome.
In these circumstances amiodarone must be initiated by a specialist and only continued in primary care under a shared care arrangement. Amiodarone should always be initiated with a treatment plan including dose schedule and when amiodarone is intended to be stopped. As such amiodarone will be considered AMBER on the traffic light system for the above indications.